Privigen 100 mg/ml solution for infusion

Privigen is a high-quality therapeutic product consisting of normal human immunoglobulin (IgG), used primarily to treat primary immunodeficiency and certain autoimmune disorders. The product is developed and manufactured by CSL Behring, a global leader in the biotherapeutics industry.

The manufacturing process for Privigen is highly specialized, involving the purification of antibodies from pooled human plasma. While CSL Behring operates a global manufacturing network, a significant portion of the production for Privigen occurs at their state-of-the-art facilities in Bern, Switzerland. The brand itself traces its heritage back to the Behringwerke, founded by Emil von Behring in Germany, though the modern corporate structure is now part of the Australian-based CSL Limited group.